Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $1.51B
Liabilities Breakdown FY2023
Total Liabilities: $873.5M
Asset Breakdown
Total Assets: $1.51B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $144.3M | 9.5% |
| Accounts Receivable | $114.9M | 7.6% |
| Inventory | $105.8M | 7.0% |
| Property, Plant & Equipment | $282.7M | 18.7% |
| Goodwill | $3.2M | 0.2% |
| Intangible Assets | $580.9M | 38.4% |
| Other Assets | $281.0M | 18.6% |
Liabilities Breakdown
Total Liabilities: $873.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $25.4M | 2.9% |
| Long-Term Debt | $603.2M | 69.1% |
| Other Liabilities | $244.9M | 28.0% |